Literature DB >> 29424452

Evidence and mechanism by which upper partial fibulectomy improves knee biomechanics and decreases knee pain of osteoarthritis.

Yong Nie ZeYu Huang1, Bin Xu1, Bin Shen1, Virginia B Kraus2,3, FuXing Pei1.   

Abstract

To investigate the change in short-term clinical outcomes and biomechanical properties of the knee in response to upper partial fibulectomy and to probe into the biomechanical mechanism underlying the clinical benefits of upper partial fibulectomy for medial compartment knee osteoarthritis (KOA). A total of 29 patients with medial compartment KOA underwent upper partial fibulectomy. Visual analog scale (VAS) pain, the hospital for special surgery knee score (HSS), hip-knee-ankle (HKA) angle (measured in the frontal plane), and flexion/extension range of motion of the knee were assessed before and up to 6 months after surgery. Patients and 20 healthy controls were evaluated by 3D gait analysis and dynamic lower limb musculoskeletal analysis. Both VAS pain and HSS score were significantly improved (p < 0.001) one day after surgery and steadily improved during the subsequent 6 months. HKA angle improved (p = 0.025) immediately and remained stable by 3 months after surgery. The decreased overall peak KAM (decreased by 11.1%) and increased HKA angle (increased by 1.80 degrees from a more varus to more neutral alignment) of affected and operated side by 6 months after surgery were observed. Muscle activity of biceps femoris caput longum of affected and operated side increased immediately and was equivalent to healthy controls by 6 months after surgery (p = 0.007). This pilot study provides biomechanical evidence of benefit from partial upper fibulectomy and indicates a plausible rationale for the improvement in clinical symptoms. Long-term clinical outcomes and precise biomechanical mechanism of partial upper fibulectomy should be further investigated.
© 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 9999:1-10, 2018. © 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  gait analysis; knee adduction moment; medial compartment knee osteoarthritis; musculoskeletal analysis; upper partial fibulectomy

Year:  2018        PMID: 29424452     DOI: 10.1002/jor.23867

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  5 in total

1.  Gait Improvement in Patients with Knee Osteoarthritis after Proximal Fibular Osteotomy.

Authors:  Xiaotong Li; Yuqing Cao; Zhenguo Cao; Pengfei Zheng; Andrew Merryweather; Hui Wang; Ding Chen; Hang Xu
Journal:  Biomed Res Int       Date:  2022-06-23       Impact factor: 3.246

2.  Comparison of Clinical and Radiological Outcomes Between Upper Fibular Curvature and Non-Curvature with Medial Knee Osteoarthritis Following Proximal Fibular Osteotomy: A Retrospective Cohort Study with Minimum 2-Year Follow-up.

Authors:  Xiang-Tian Deng; Hong-Zhi Hu; Zhong-Zheng Wang; Jian Zhu; Sifan Yang; Yu-Chuan Wang; Zhi-Peng Ye; Hai-Tao Guan; Bo-Yu Zhang; Xiao-Dong Cheng; Ying-Ze Zhang
Journal:  Orthop Surg       Date:  2021-05-20       Impact factor: 2.071

3.  Proximal Fibular Osteotomy for Medial Compartment Knee Osteoarthritis: Is It Worth?

Authors:  Najmul Huda; Mir Shahid Ul Islam; Hemant Kumar; Ajay Pant; Sandeep Bishnoi
Journal:  Indian J Orthop       Date:  2020-06-09       Impact factor: 1.251

4.  Proximal Fibular Osteotomy: Is it Really an Option for Medial Compartmental Osteoarthritis Knee? Our Experience at Tertiary Centre.

Authors:  Aamir Bin Sabir; Mohd Faizan; Vishal Singh; Latif Z Jilani; Sohail Ahmed; Ziaul Hoda Shaan
Journal:  Indian J Orthop       Date:  2020-10-28       Impact factor: 1.251

5.  Comparison of Clinical and Biomechanical Outcomes between Partial Fibulectomy and Drug Conservative Treatment for Medial Knee Osteoarthritis.

Authors:  Guo Chen; Bin Xu; Jinwei Xie; Yong Nie; Shuo Tang; Jun Ma; Qiang Huang; Zongke Zhou; Bin Shen; Xia Li; Hai Shen; Fuxing Pei
Journal:  Biomed Res Int       Date:  2019-10-30       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.